HSD17B2: 17β-Hydroxysteroid Dehydrogenase Type 2

Key enzyme in steroid hormone metabolism and estrogen inactivation

Gene Information Card

Symbol HSD17B2
Full Name Hydroxysteroid 17-Beta Dehydrogenase 2
Gene Type Protein coding
Chromosomal Location 16q24.1
NCBI Gene ID 3294 ncbi.nlm.nih.gov/gene/3294
Ensembl ID ENSG00000131095
UniProt ID P37059
OMIM ID 109685
HGNC ID 5212
Aliases 17β-HSD2, EDDH2, SDR11C2

Description

HSD17B2 encodes 17β-hydroxysteroid dehydrogenase type 2, a member of the short-chain dehydrogenase/reductase (SDR) family. This enzyme catalyzes the NAD+-dependent oxidation of 17β-hydroxysteroids, including estradiol to estrone and testosterone to androstenedione, thereby inactivating potent sex steroids. It plays a critical role in regulating local steroid hormone levels in target tissues such as placenta, endometrium, and breast.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer Reduced HSD17B2 expression leads to local estradiol accumulation, promoting estrogen-dependent tumor growth. PMID: 10652318
Endometriosis Decreased HSD17B2 activity in endometriotic tissue impairs inactivation of estradiol, contributing to lesion proliferation. PMID: 12574206
Prostate Cancer Altered HSD17B2 expression affects androgen metabolism, potentially influencing tumor progression. PMID: 15634788
Polycystic Ovary Syndrome (PCOS) Variants in HSD17B2 may disrupt steroidogenesis, contributing to hyperandrogenism. PMID: 16984928

Expression Profile

Tissue Expression
Tissue nTPM level
Placenta 78.5 High
Liver 45.2 High
Endometrium 32.1 Medium
Breast 18.7 Medium
Prostate 12.3 Low
Adrenal Gland 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
MCF-7 (breast cancer) 15.4 Moderate expression
HepG2 (liver cancer) 42.1 High expression
LNCaP (prostate cancer) 10.2 Low expression
JEG-3 (placental choriocarcinoma) 68.9 Very high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.325G>A (p.Gly109Arg) Missense <0.01% Reduced enzyme activity; associated with altered steroid metabolism
c.534C>T (p.Ser178Leu) Missense <0.01% Decreased catalytic efficiency
c.787G>A (p.Gly263Arg) Missense <0.01% Potential loss of function; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Missense variants such as p.Gly109Arg and p.Ser178Leu reduce or abolish 17β-HSD2 enzymatic activity, leading to impaired estradiol inactivation.

Gain of Function (GOF)

No gain-of-function mutations have been reported for HSD17B2.

Dominant Negative (DN)

No dominant-negative mutations have been described for HSD17B2.

Pathways

Steroid hormone biosynthesis (KEGG: hsa00140)
Metabolism of steroids (Reactome: R-HSA-196071)
Estrogen metabolism (Reactome: R-HSA-196069)

Protein Summary

HSD17B2 is a 387-amino acid protein localized to the endoplasmic reticulum membrane. It functions as a homodimer and uses NAD+ as a cofactor to oxidize 17β-hydroxysteroids, thereby reducing the biological activity of estrogens and androgens. The enzyme is highly expressed in placenta, liver, and endometrium, where it protects tissues from excessive steroid hormone stimulation. Its activity is crucial for maintaining hormonal balance in reproductive tissues and for the inactivation of circulating sex steroids.

Related Products

Product name Cat.No. Species Gene ID
HSD17B2 Knockout HEK293 Cell Line EDJ-KQ4940 Human 3294 Details Get a Quote
HSD17B2 Knockout HeLa Cell Line EDJ-KQ53578 Human 3294 Details Get a Quote
HSD17B2 Knockout A-549 Cell Line EDJ-KQ62044 Human 3294 Details Get a Quote
HSD17B2 Knockout HCT 116 Cell Line EDJ-KQ70526 Human 3294 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: